Elafibranor for previously treated primary biliary cholangitis (TA1016)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 14 November 2024
Avatrombopag for treating thrombocytopenia in people with chronic liver disease needing a planned invasive procedure (TA626)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 24 June 2020
Lusutrombopag for treating thrombocytopenia in people with chronic liver disease needing a planned invasive procedure (TA617)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 8 January 2020
Obeticholic acid for treating primary biliary cholangitis (TA443)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 26 April 2017
Everolimus for preventing organ rejection in liver transplantation (TA348)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 22 July 2015
Rifaximin for preventing episodes of overt hepatic encephalopathy (TA337)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 25 March 2015